Analysts expect Arcus Biosciences, Inc. to report revenue of 10.44 M for Q3 26, against a range of 10.02 M to 10.86 M. The most recent reported quarter, Q2 26, came in at 41.00 M, a 99.7% beat against the 20.53 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 48.00 M | 36.00 M | 28.00 M | 160.00 M | 26.00 M | 33.00 M | 17.00 M | 41.00 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 44.02 M | 32.61 M | 38.01 M | 37.56 M | 22.93 M | 39.18 M | 33.60 M | 22.32 M | 10.86 M | 7.25 M | 6.70 M | 7.38 M | 4.81 M | 4.51 M | 37.86 M | 73.95 M | ||||||||||
| Low Estimate | 36.30 M | 27.87 M | 34.26 M | 33.27 M | 20.03 M | 36.58 M | 27.85 M | 18.74 M | 10.02 M | 6.23 M | 6.08 M | 6.46 M | 4.12 M | 3.95 M | 32.19 M | 66.72 M | ||||||||||
| Consensus Estimate | 40.16 M | 30.24 M | 36.14 M | 35.41 M | 21.48 M | 37.88 M | 30.72 M | 20.53 M | 10.44 M | 6.74 M | 6.39 M | 6.92 M | 4.47 M | 4.23 M | 35.03 M | 70.33 M |
Analysts expect Arcus Biosciences, Inc. to report earnings per share of -0.92 for Q3 26, against a range of -0.98 to -0.86. The most recent reported quarter, Q2 26, came in at -0.72, a 15.3% beat against the -0.85 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.00 | -1.03 | -1.14 | 0.00 | -1.27 | -0.89 | -1.02 | -0.72 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.94 | -1.08 | -0.89 | -1.01 | -1.30 | -1.07 | -0.77 | -0.82 | -0.86 | -0.84 | -0.83 | -0.91 | -1.09 | -0.84 | -0.47 | -0.42 | ||||||||||
| Low Estimate | -1.04 | -1.26 | -1.05 | -1.09 | -1.44 | -1.25 | -0.91 | -0.88 | -0.98 | -0.96 | -0.93 | -1.07 | -1.29 | -0.96 | -0.53 | -0.50 | ||||||||||
| Consensus Estimate | -0.99 | -1.17 | -0.97 | -1.05 | -1.37 | -1.16 | -0.84 | -0.85 | -0.92 | -0.90 | -0.88 | -0.99 | -1.19 | -0.90 | -0.50 | -0.46 |
Pull Wall Street consensus for Arcus Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RCUS&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RCUS", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RCUS&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();